The pharmaceutical circuit of Advanced Therapy Medicinal Products—guidelines of the French Society for Oncology Pharmacy
These new SFPO guidelines are unique in that they provide the first comprehensive framework addressing the entire hospital circuit for ATMPs, including oncology and nononcology applications. Recommendations encompass a broader scope, including containment strategies, waste management and pharmaceutical responsibilities. These guidelines provide a comprehensive, structured and evidence-based framework for managing ATMPs within hospital settings. By addressing both clinical and logistical challenges, they aim to improve patient safety, ensure regulatory compliance and enhance the efficiency of ATMP workflows.
Authors
- Sandra Ruitort
- Romain de Jorna (ORCID: https://orcid.org/0000-0003-4843-3123)
- Marine Pinturaud
- Miryam Mebarki (ORCID: https://orcid.org/0000-0003-3413-0463)
- Catherine Rioufol (ORCID: https://orcid.org/0000-0002-9728-8092)
- Adeline Quintard
- Bertrand Pourroy (ORCID: https://orcid.org/0000-0002-2388-3518)
- Isabelle Madelaine
- Catherine Devys
- Muriel Carvalho
- Laurence Escalup
Institutions
- Université de Montpellier (FR)
- Université Paris Cité (FR)
- Université de Lille (FR)
- Saint Louis University Hospital (US)
- Assistance Publique Hôpitaux de Marseille (FR)
- Lille’s Cardiology Hospital (FR)
- Centre Hospitalier Universitaire de Montpellier (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hospices Civils de Lyon (FR)
- Institut de Cancérologie de l'Ouest (FR)
- Hôpital Lyon Sud (FR)
- Hôpital l'Archet (FR)
- Hôpitaux Universitaires Henri-Mondor (FR)
- Physique des Cellules et Cancers (FR)
- Institut Curie (FR)
- HCL Technologies (India) (IN)
Publication Details
- Journal
- Cytotherapy
- Published
- 2025-04-18
- DOI
- https://doi.org/10.1016/j.jcyt.2025.04.065
- Citations
- 3
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 3.14